Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
Insider tradingForm 4

ADARx Pharmaceuticals, Inc. (ADRX) Insider Trading

5 open-market trades reported since Sep 29, 2026: 5 purchases worth $87.7M and 0 sales worth $0.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Orbimed Advisors LLCDirector1$16.1M0$0Sep 30, 2026
Carl L. GordonDirector1$16.1M0$0Sep 30, 2026
Erez ChimovitsDirector1$1.05M0$0Sep 30, 2026
Simeon GeorgeDirector1$27.2M0$0Sep 29, 2026
Sr One Capital Management, LLC10% owner1$27.2M0$0Sep 29, 2026
ADVERTISEMENT
728 × 90 ad slot320 × 100 ad slot

All trades

ADRX insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Sep 30Sep 28Orbimed Advisors LLCDirectorDirector (ind.)▲ BUY950,00017.00$16.1M+11%Form 4 ↗
Sep 30Sep 28Carl L. GordonDirectorDirector (ind.)▲ BUY950,00017.00$16.1M+11%Form 4 ↗
Sep 30Sep 28Erez ChimovitsDirectorDirector (ind.)▲ BUY61,51617.00$1.05M+0.7%Form 4 ↗
Sep 29Sep 28Simeon GeorgeDirectorDirector (ind.)▲ BUY1,600,00017.00$27.2MNewForm 4 ↗
Sep 29Sep 28Sr One Capital Management, LLC10% owner10% owner (ind.)▲ BUY1,600,00017.00$27.2MNewForm 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings